Author: Hoffman V.F. Skiest D.J.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.9, Iss.2, 2000-02, pp. : 207-220
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Comparative Tolerability of Therapies for Cytomegalovirus Retinitis
By Walmsley S.
Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. :
Alemtuzumab: Cytomegalovirus retinitis: case report
Reactions Weekly, Vol. 1, Iss. 1253, 2009-01 ,pp. :
Methylprednisolone/prednisone: Cytomegalovirus retinitis: case report
Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. :
Therapeutic patents for cytomegalovirus
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. :
Recent developments in antiviral drugs for cytomegalovirus
By Emery Vincent C Milne Richard SB
Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. :